In accordance with the Department of Biotechnology (DBT), Government of India, Regional Centre of Biotechnology (RCB) has established an Institutional Biosafety committee (IBSC). The IBSC oversees research with the potentially hazardous biological agents in the Centre.
The primary mission of the IBSC is to ensure the safety of faculty, staff, students and the researchers involved in the biological research at the Centre, and also to protect the general public and the environment from adverse consequences related to that research. The work of the IBSC supports the Centre in meeting all required standards set by the DBT and as necessary, developing specific policies to make any research conducted with hazardous or potentially hazardous biological agents (either naturally occurring or synthetically created) as safe as possible.
The IBSC is composed of nine members so selected that they collectively have experience and expertise in recombinant DNA (rDNA) technology and the capacity to assess the safety of recombinant DNA research and other infectious agents to identify any potential risk to public health or the environment. The IBSC of our Centre is constituted as per the DBT, Govt. of India guidelines and the constitution is as follows:
Chairperson
|
:
|
Dr. Prasenjit Guchhait, Professor, RCB, Faridabad
|
DBT Nominee
|
:
|
Dr. Dhiraj Kumar, Group Leader, ICGEB, New Delhi
|
Member Secretary
|
:
|
Dr. Tushar Kanti Maiti, Associate Professor, RCB, Faridabad
|
External Expert(s)
|
:
|
Dr. Ramandeep Singh, Associate Professor, THSTI, Faridabad
|
:
|
Dr. Ananda K. Sarkar, Staff Scientist, NIPGR, New Delhi
|
|
Biosafety Officer
|
:
|
Dr. Nitya Wadhwa, Scientist, PBC, THSTI, Faridabad
|
Internal Expert(s)
|
:
|
Dr. Chittur V Srikanth, Associate Professor, RCB, Faridabad
|
:
|
Dr. Sam J Mathew, Assistant Professor, RCB, Faridabad
|
|
:
|
Dr. Divya Chandran, Assistant Professor, RCB, Faridabad
|
The IBSC is responsible for reviewing the research with potential hazardous biological agents and rDNA technology in order to assess whether the biosafety containment levels proposed are adequate to protect researchers, the public and the environment from the risk proposed by the work.
The IBSC will determine approval or disapproval of the proposed experiments through review of the application submitted by the principal investigator along with supporting materials as needed. This review and oversight involves independent assessment of the biosafety containment level proposed for the work and through coordination with the biological safety officer, assessment of facilities, procedures, practices, training and expertise of personnel involved in the research.
Specifically, the IBSC is charged with the review and oversight of research with the following potentially hazardous biological agents and experiments:
The IBSC has to meet at least twice a year to review the status of rDNA projects in the institution. It is important that the Chairman and Member Secretary ensure that regular meetings take place.
More than two meetings may be held as per requirement of the projects. The IBSC members are expected to look into the following during the meetings:
The role of IBSC assumes major importance in the regulatory framework since it is a Statutory Committee that operates from the premises of the institution and hence is in a position to conduct onsite evaluation, assessment and monitoring of adherence to the biosafety guidelines. The functions in the IBSC of the head of the organization, members, DBT nominees, and Principal Investigator are explained below:
Chairman of IBSC
DBT Nominee
The IBSC has a nominee from DBT who oversees the activities to ensure that safety aspects are being fully adhered to by the organization. The DBT nominee serves as the link between the department and the respective IBSC. In addition to the responsibilities as an IBSC member, the duty of the DBT nominee is to ensure that:
Principal Investigator
All recombinant research projects carried out by an organization have a Principal Investigator (PI) and it is the duty of the PI to apprise the IBSC about the nature of the experiments being carried out. Depending upon the risk category, the PI has to inform the IBSC, seek permission of IBSC before starting the experiments or seek permission of the RCGM through its IBSC.
The PI is primarily responsible for ensuring compliance with biosafety standards. The PI functions as a project manager as well as a researcher, communicating with the IBSC and bearing responsibility for training and supervising personnel.
Based on the nature of the GMO or the infectious agent, the PI determines the proper containment level for the project and, in accordance with the DBT Guidelines, develops the necessary experimental protocols. This information is then submitted to IBSC for review.
The responsibilities of PI to IBSC are summarized below:
Laboratory Personnel (Technician, Technologist, Student, Post-doctorate, Young Investigators)
THE Laboratory personnel must:
Follow all safety guidelines and establish good laboratory practices. They must work within the assigned biological safety containment level and use personal protective equipment as recommended by the PI.
The role of IBSC in rDNA activities within an organization is broadly categorized into research, large-scale experiments/production/field release and import and shipment.
The DBT Guidelines for rDNA Safety Guidelines of DBT (http://www.dbtindia.nic.in) stipulate three categories of research activities i.e. Category I, II and III with increasing level of containment requirements.
Depending upon the category of experiments, IBSC can simply note the information provided by PI, give permission before the start of the experiments or forward it to RCGM for approval.
Large scale trials and production
Although the approval for small scale field trials fall under the purview of RCGM and approval for large-scale trials and production needs to be taken from GEAC, as per the Rules 1989, in all these cases, IBSC has an extremely important role in terms of verifying the information being forwarded to RCGM and GEAC in terms of physical containment conditions, categorization in terms of risk assessment etc. being the statutory body functioning on the premises of the institution. Both RCGM and GEAC depend on the review of the IBSC on the submissions made.
IBSC has to recommend emergency plan in case of large-scale operations, as and when required, which would be then approved by competent authorities. Emergency plan shall include methods and procedures for handling large losses of cultures and organisms.
Import and shipment
The interstate shipment of indigenous etiological agents, diagnostic specimens and biological products need clearance of IBSC and is subject to appropriate packaging, labelling and shipping requirements.
The import of regulated materials for research (e.g. toxin genes, hybridomas, cell cultures, organelle) and specifying conditions under which the agent or vector is shipped, handled and use are issued by RCGM. In case of plants, the import is routed through the Director, National Bureau of Plant Genetic Resources on the basis of the import permit issued by the DBT, based on recommendations of the RCGM. However, all these proposals need to be submitted by the PIs through thei IBSC.
Assignment of Biosafety Levels (BL) - It is the responsibility of the PI to initially assign the BL to his/her protocol. This level may be changed either upward or downward during review by the IBSC. All parties involved in assigning BLs will follow the standard levels of 1, 2 or 3 as outlined in DBT’s Guidelines for Research Involving Recombinant DNA Molecules. These are summarized below.
Table: Categorization of microorganisms based on pathogenicity |
|
Hazard Group 1 |
Organisms that are most unlikely to cause human disease |
Hazard Group 2 |
Organisms capable of causing human disease and which may be a hazard to laboratory workers, but are unlikely to spread to the community. Laboratory exposure rarely produces infection and effective prophylaxis or effective treatment is usually available |
Hazard Group 3 |
Organisms that may cause severe human disease and present a serious hazard to laboratory workers. They may present a risk of spreading to the community, but there is usually effective prophylaxis or treatment available |
Hazard Group 4 |
Organisms that cause severe human disease and are a serious hazard to laboratory workers. They may present a high risk of spreading to the community, and there is usually no effective prophylaxis or btreatment |
The details of microorganisms falling into each category are given in the Recombinant DNA Biosafety Guidelines, 1990.
Containment facilities
In general, biosafety begins with ensuring the workplace, whether it is a laboratory or open fields, is safe for the working staff, the general population and the environment by proper containment.
The containment could be physical, where there are real barriers to prevent escape, or biological where the organism is designed not to be able to survive in any environment other than that of the laboratory. The containment facilities and biosafety practices have been defined in detail in “Recombinant DNA Safety Guidelines, 1990” of DBT. A summary of recommended biosafety levels for infectious agents is given below.
Table: Recommended Biosafety Levels for Infectious Agents
Biosafety Level
|
PracticeandTechniques
|
Safety
|
Facilities
|
1.
|
Standard microbiological practices
|
Non-primary containment provided by adherence to standard laboratory practices
|
Basic
|
2.
|
Level 1 practices plus laboratory coats; decontamination of all infectious wastes, limited access, protective gloves and biohazard warning signs as indicated
|
Partial containment equipment (i.e. Class I or II Biological Safety Cabinets) used to conduct mechanical and manipulative procedures that have aerosol potential that may increase the risk of exposure to personnel
|
Basic
|
3.
|
Level 2 practices plus special laboratory clothing, controlled access
|
Partial containment equipment used for all manipulations of infectious material
|
Containment
|
4.
|
Level 3 practices plus entrance through change room where street clothing is changed
|
Maximum containment equipment (i.e. class III biological safety cabinet or partial containment)
|
Maximum containment
|
The code of practice for a basic laboratory applies as follows except where modified:
Incubators can become the inadvertent and undesired repository of microorganisms. Although they may present a hazard to laboratory workers, most often they are a source of contamination of laboratory cultures. Besides the moist surfaces, rubber gaskets, the humidity trough if present, and the fan mechanism are areas in which contaminating microorganisms concentrate.
Use this type of hood only for the removal of vapors released or generated by chemical reactions involving mildly toxic materials, acids (not heated), and organic solvents. In this type of hood, do not use hot perchloric acid, hot concentrated acids, highly toxic materials, unstable chemicals or explosive.
Use this type of hood only for the removal of vapors released or generated by chemical reactions involving mildly toxic
PI should maintain a document accessible to all lab personnel, with a list of procedures to be followed in case of an accident such as a spill, injection, ingestion, aerosolization, splash, etc. The document should have the information on agent specific actions, known first aid procedures, effective disinfectants / neutralizing agents (include location in lab), and known symptoms associated with exposures to the agent(s). In case of emergency, please call Principal Investigator, Security, emergency medical personnel etc., and inform the IBSC.
It is the responsibility of the PI to make appropriate notifications in the wake of an occupational exposure, laboratory accident, loss of potential containment, etc. The IBSC should be notified of incidents or adverse events involving biological agents or toxins.
In case of accidental exposure to infectious material e.g., infected body fluid, pathogenic strains etc., prophylaxis measures should be initiated as follows:
Records of appropriate training (technical, safety, procedural, etc.) of lab personnel should be maintained. PI should ensure enrolment of new lab personnel to biosafety training and notify the IBSC on December 1st of each year about training status of all lab personnel.
The Biosafety Officer will assess requirement of vaccination for students and staff working in various laboratories depending on the micro-organism used and the level of exposure. A regular regime will be followed with documentation of baseline serum values and subsequent values for different antibodies as decided by the Biosafety Officer.
Listed below are the materials necessary to develop a fairly inexpensive general spill kit for a laboratory. This kit should be able to handle <1 litre of most acids, bases, and solvents found in a typical laboratory. Do not attempt to clean up a spill of greater volume. The following materials shall constitute a general laboratory spill kit.
This general chemical spill kit is not meant for use with mercury, hydrofluoric acid, sodium metal, cytotoxic drugs, and numerous other chemicals. It is the responsibility of all laboratory personnel to evaluate a potential spill and develop spill response procedures for the specific hazards present. This kit can be modified to meet the needs of your laboratory. Refer to the MSDSs for the chemicals handled in the lab to identify if special spill materials are needed.
Follow these procedures for cleaning-up spills of blood and blood products. The same procedures can be used for cleaning up other body fluids. For any assistance call IBSC. Prior to beginning the clean-up, wear personal protecting equipment (PPE) i.e. rubber, latex, PVC or similar type gloves, lab coat etc.
13.0 WASTE DISPOSAL
As per Section 6, 8 and 25 of the Environment (Protection) Act, 1986 of the Central Government the waste must be disposed-off in the following manner.
Cat. No. |
TypeofWaste |
Examples |
Treatment&Disposal |
1 |
Human anatomical waste |
human tissues, organs, body parts |
Incineration@/deep burial* |
2 |
Animal waste |
animal tissues, organs, body parts, carcasses, bleeding parts, fluid, blood and experimental animals used in research, waste generated by veterinary hospitals colleges, discharge mfrom hospitals, animal houses |
Incineration@/deep burial* |
3 |
Microbiology & Biotechnology waste |
wastes from laboratory cultures, stocks or specimens of micro-organisms, live or attenuated vaccines, human and animal cell culture used in research and infectious agents from research laboratories, wastes from production of biologicals, toxins, dishes and devices used for transfer of cultures |
local autoclaving/micro-waving/incineration@ |
4 |
Sharps contaminated with biological waste |
needles, syringes, scalpels, blades, glass, etc. that may cause puncture and cuts. This includes both used and unused sharps |
disinfection (chemical treatment@ /autoclaving /micro- waving and mutilation/shredding## |
5 |
Discarded medicine & cytotoxic drugs |
wastes comprising of outdated, contaminated and discarded medicines |
incineration@/ destruction and drugs disposal in secured landfills |
6 |
Solid waste contaminated with biological sample |
Items contaminated with blood, and body fluids including cotton, dressings, soiled plaster casts, lines, beddings, other material contaminated with blood |
Incineration@ / autoclaving / microwaving |
7 |
Solid waste |
wastes generated from disposable items other than the waste sharps such as tubings, catheters, intravenous sets etc. |
treatment@@ /autoclaving / microwaving and mutilation/shredding## |
8 |
Liquid waste |
waste generated from laboratory and washing, cleaning, house-keeping and disinfecting activities |
disinfection by chemical treatment@@ and discharge into drains |
9 |
Incineration ash |
ash from incineration of any bio-medical waste |
disposal in municipal landfill |
10 |
Chemical waste |
chemicals used in production of biologicals, chemicals used in chemical disinfection, as insecticides, etc. |
chemical treatment@@ and discharge into drains for fluids and secured landfill for solids |
@@ Chemicals treatment using at least 1% hypochlorite solution or any other equivalent chemical reagent. It must be ensured that chemical treatment ensures disinfection.
##Mutilation/shredding must be such so as to prevent unauthorized reuse.
@There will be no chemical pretreatment before incineration. Chlorinated plastics shall not be incinerated.
* Deep burial shall be an option available only in towns with population less than five lakhs and in rural areas.
Colour coding and type of container for disposal of bio-medical wastes
ColourCoding |
TypeofContainer- WasteCategory |
Treatmentoptions |
Yellow |
Plastic bag Cat. 1, Cat. 2, Cat. 3, Cat. 6 |
Incineration/deep burial |
Red |
Disinfected container/plastic bag Cat. 3, Cat. 6, Cat. 7 |
Autoclaving/Microwaving/ Chemical Treatment |
Blue/White translucent |
Plastic bag-puncture proof container. Cat. 4, Cat. 7 |
Autoclaving/Microwaving/ Chemical Treatment and destruction/shredding |
Black |
Plastic bag Cat. 5, Cat. 9, Cat. 10 (solid) |
Disposal in secured landfill |